Black Arch II LP is a private investment fund based in Kaysville, Utah. Its most recent Form D, filed Oct 22, 2026, reports no sales yet. The minimum investment it accepts from an outside investor is $100,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(c), which permits general advertising to investors verified as accredited. Related persons named in the filing include Dustin Kearl; Zach Smith.
- Total raised
- $0Cumulative sales reported on Form D
- Investors
- 0
- First sale
- —
- Minimum investment
- $100,000
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(c)May advertise; investors must be verified as accredited
- Key people and entities
- Dustin Kearl; Zach Smith
- Latest Form D
- Oct 22, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Black Arch II LP
What is the minimum investment for Black Arch II LP?
According to its latest Form D, filed Oct 22, 2026, the minimum investment Black Arch II LP accepts from an outside investor is $100,000.
Who can invest in Black Arch II LP?
Black Arch II LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(c), so it may advertise, but every investor must be verified as accredited.
How much has Black Arch II LP raised?
Black Arch II LP's latest Form D, filed Oct 22, 2026, reports no sales yet.
Where is Black Arch II LP based?
Black Arch II LP is based in Kaysville, Utah.
Size compared with every private investment fund
This fund hasn't reported any sales yet.